SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PARANOID! TIRED OF TALKING TO YOURSELF? LET'S TALK(TTP)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Arthur Radley who started this subject11/16/2000 1:32:21 PM
From: nigel bates  Read Replies (1) of 626
 
Nov. 16, 2000--Titan Pharmaceuticals, Inc. (AMEX: TTP - news) today announced that it has entered into definitive purchase agreements for the sale of 1.2 million shares of newly issued common stock to selected institutional investors for $43.8 million. The purchase price is $36.50 per share. Following completion of this private placement, the Company will have approximately 27.2 million shares outstanding. The Company expects to file a registration statement on Form S-3 within 15 days after closing of the transaction for purposes of registering the shares of common stock issued in the private placement.
Titan may use the net proceeds of the offering to advance additional product indications in Phase III human testing, to acquire or in-license additional technologies or products, and for working capital and other general corporate purposes...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext